Ontology highlight
ABSTRACT: Background
The SARS-CoV-2 Omicron variant caused a large-scale outbreak of COVID-19 in Shanghai, China. Patients with inflammatory bowel disease (IBD) are at high risk of infection due to immunosuppressive interventions. We aimed to investigate the vaccination information of patients with IBD and update a vaccination guide based on a comparison of vaccination in asymptomatic carriers and healthy individuals.Methods
This retrospective study was conducted during an Omicron variant wave. We assessed the vaccination status in patients with IBD, asymptomatic carriers and healthy individuals. Factors with unvaccinated status and adverse events following vaccination were also determined in patients with IBD.Results
The vaccination rate was 51.2% in patients with IBD, 73.2%
SUBMITTER: Feng J
PROVIDER: S-EPMC10313391 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature